A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response

Published:2015-11 Issue: Volume:24 Page:S23-S25
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Viale Giuseppe

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference23 articles.

1. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31;Pogue-Geile;J Natl Cancer Inst,2013

2. PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancer;Cescon;J Clin Oncol,2015

3. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009;Goldhirsch;Ann Oncol,2009

4. Molecular portraits of human breast tumours;Perou;Nature,2000

5. Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;Goldhirsch;Ann Oncol,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology;npj Breast Cancer;2023-04-06

2. A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer;The Breast;2018-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3